BMO's Physician Survey Results Indicate Good Health Of Endologix
July 07, 2016 at 13:40 PM EDT
BMO Capital upgraded Endologix, Inc. (NASDAQ: ELGX) to Outperform from Market Perform, increasing the price target to $16 from ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.